Chief Medical Officer And Head Of R&D at Cognition Therapeutics, Inc.
New York, United States
Join Prog.AI to see contacts
Join Prog.AI to see contacts
Summary
👤
Senior
🎓
Top School
Anthony Caggiano is a therapeutic development executive and physician-scientist with over two decades of leadership advancing CNS and cardiovascular drug programs from discovery through clinical development and commercialization. As Chief Medical Officer and Head of R&D at Cognition Therapeutics and prior senior roles at Acorda and multiple biotech startups, he has led IND filings, scaled clinical operations, and negotiated strategic partnerships and licensing deals. He specializes in neurodegenerative and acute neurotrauma indications—Alzheimer’s, Parkinson’s, stroke, TBI, MS—and has orchestrated programs spanning small molecules, biologics, and innovative modalities. Anthony combines deep translational neuroscience training (MD/PhD, UChicago) with hands-on entrepreneurial experience founding a teleradiology company, giving him rare fluency across science, clinical strategy, and operational execution. Known for building cross-functional teams and investor-facing development plans, he also brings a practical passion for product-focused web tools on the side, reflecting a habit of shipping useful tech beyond the lab.
10 years of coding experience
18 years of employment as a software developer
MD PhD Neuroscience and Medicine, MD PhD Neuroscience and Medicine at The University of Chicago Pritzker School of Medicine
BA Chemistry Biology and Psychology, BA Chemistry Biology and Psychology at University of Virginia
Django app to help me choose and keep track of the t-shirts I wear.
Contributions:2 PRs, 8 pushes, 4 branches in 3 years 11 months
pythonkeept-shirtsdjangowear
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Anthony Caggiano - Chief Medical Officer And Head Of R&D at Cognition Therapeutics, Inc.